Allergan Buys Serica Technologies

Xconomy Boston — 

Medford, MA-based biomaterials provider Serica Technologies was acquired late last year by Allergan, the health care products company that makes onabotulinumtoxinA (Botox). Irvine, CA-based Allergan (NYSE:AGN) revealed the buyout in its earnings report yesterday, but did not disclose the acquisition costs. Some of the investors in Serica, which will operate as subsidiary of Allergan in Medford, include Needham, MA-based venture firm Prism VentureWorks, Ivy Capital Partners, of Montvale, NJ, and Morningside Technology Ventures, an investment group with founders from Hong Kong, according to a press release from yesterday.

By posting a comment, you agree to our terms and conditions.

Comments are closed.